Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | PPM1B | O75688 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16134086 | 1.00 | MAPT (0.45) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL31009727 | 1.00 | MAPT (0.45) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL1169394 | 0.86 | MAPT (0.52) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL12035330 | 0.85 | MAPT (0.42) | MAPTALDH1A1MEN1KMT2ACYP3A4 | |
| SCHEMBL16134085 | 0.85 | MAPT (0.42) | MAPTALDH1A1MEN1KMT2ACYP3A4 | |
| SCHEMBL1196227 | 0.85 | MAPT (0.42) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL17131599 | 0.85 | PPM1B (0.45) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL31009744 | 0.85 | PPM1B (0.45) | MAPTALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL16134088 | 0.84 | MAPT (0.41) | MAPTALDH1A1MEN1KMT2ACYP3A4 | |
| SCHEMBL16674652 | 0.84 | MAPT (0.41) | MAPTALDH1A1PPM1BPTPN1PPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPT 1867/4885ALDH1A1 1292/4885PPM1B 4095/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPT 1867/4885ALDH1A1 1292/4885PPM1B 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.